The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.77BCNY
413.08M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue (TTM)
340.72MCNY
50.88M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
-21.31%
Updated Sep 22, 2026
Beta
0.8170x
vs all stocks
Updated Sep 22, 2026
52-Week Change
21.43%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
2.77BCNY
413.08M · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
2.98BCNY
445.50M · vs all stocks (USD)
Updated Sep 22, 2026
Price to Sales (TTM)
8.03x
Updated Sep 22, 2026
Price to Book (MRQ)
5.67x
Updated Sep 22, 2026
Enterprise to Revenue
8.76x
Updated Sep 22, 2026
Gross Margin
47.78%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 40.45%.Updated Sep 22, 2026
Profit Margin
-21.31%
Updated Sep 22, 2026
Operating Margin
-1.53%
Updated Sep 22, 2026
Return on Assets (TTM)
-2.04%
Updated Sep 22, 2026
Return on Equity (TTM)
-13.96%
Updated Sep 22, 2026
Revenue (TTM)
340.72MCNY
50.88M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
0.9430CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
4.40%
Updated Sep 22, 2026
Gross Profit (TTM)
137.83MCNY
20.58M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
39.53MCNY
5.90M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
-72.62MCNY
-10.84M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
4.43%
Updated Sep 22, 2026
Operating Cash Flow (TTM)
-11.76MCNY
-1.76M · vs all stocks (USD)
Updated Sep 22, 2026
Payout Ratio
0.00%
Updated Sep 22, 2026
Minority Interest (Equity)
160.20KCNYFY2025 · Dec 31, 2025
Revenue
363.42MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
179.67MCNYFY2025 · Dec 31, 2025
Gross Profit
183.75MCNYFY2025 · Dec 31, 2025
Operating Income
15.49MCNY
2.31M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-56.83MCNYFY2025 · Dec 31, 2025
Income Tax Expense
6.23MCNYFY2025 · Dec 31, 2025
Net Income
-63.06MCNYFY2025 · Dec 31, 2025
EBIT
-45.36MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
39.53MCNYFY2025 · Dec 31, 2025
Research & Development
2.10MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
56.12MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
30.03MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
22.16KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
11.46MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.1900CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.1900CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
331.89MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
331.89MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-63.06MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
0.00CNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-50.21MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-50.58MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
49.51MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-63.06MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
12.31MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-31.11MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
31.66MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-371.29KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-371.29KCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
143.80MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-117.70MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-9.82MCNYFY2025 · Dec 31, 2025
Other Financing Charges
9.76MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
26.04MCNYFY2025 · Dec 31, 2025
Shares Outstanding
332.08MSharesUpdated Sep 22, 2026
Float Shares
216.45MSharesUpdated Sep 22, 2026
% Held by Insiders
35.83%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
3.39%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
45.44MCNY
6.79M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
0.1370CNYUpdated Sep 22, 2026
Total Debt (MRQ)
292.24MCNY
43.64M · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
0.6055x
Updated Sep 22, 2026
Current Ratio (MRQ)
1.26x
Updated Sep 22, 2026
Book Value per Share (MRQ)
1.45CNYUpdated Sep 22, 2026
Total Assets
986.32MCNY
147.29M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
513.95MCNYFY2025 · Dec 31, 2025
Total Liabilities
489.12MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
472.37MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
90.41MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
398.71MCNYFY2025 · Dec 31, 2025
Cash
49.51MCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.97MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
53.47MCNYFY2025 · Dec 31, 2025
Accounts Receivable
13.91MCNYFY2025 · Dec 31, 2025
Inventory
383.56MCNYFY2025 · Dec 31, 2025
Accounts Payable
66.75MCNYFY2025 · Dec 31, 2025
Short-term Debt
149.06MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
69.04MCNYFY2025 · Dec 31, 2025
Long-term Debt
54.01MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
14.79MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
332.08MCNYFY2025 · Dec 31, 2025
Retained Earnings
-432.64MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
497.20MCNY
74.25M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
5.71CNYUpdated Sep 22, 2026
52-Week High
14.52CNYUpdated Sep 22, 2026
52-Week Change
21.43%
vs all stocks
Updated Sep 22, 2026
Beta
0.8170x
vs all stocks
Updated Sep 22, 2026
50-Day MA
7.92CNYUpdated Sep 22, 2026
200-Day MA
7.49CNYUpdated Sep 22, 2026
Avg 10-Day Volume
18.54MSharesUpdated Sep 22, 2026
Avg 30-Day Volume
15.54MSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
-0.2200CNYUpdated Sep 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.48Profit Margin: -0.21
Financial Health
Altman Z-Score 3.14: safe zoneNotable
Altman Z-Score: 3.14
Supply Chain
Upstream position: supplies 6 industries, depends on 0Notable
Outgoing: 6.00Incoming: 0.00
Companies that share the same coordination system — how they create, deliver, or capture value.